# Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial

> **NCT03371797** · — · COMPLETED · sponsor: **PharmEvo Pvt Ltd** · enrollment: 800 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Valsartan, Amlodipine -

## Key facts

- **NCT ID:** NCT03371797
- **Lead sponsor:** PharmEvo Pvt Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-20
- **Primary completion:** 2018-10-01
- **Final completion:** 2018-11-05
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2018-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03371797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03371797, "Amlodipine VaLsartan Efficacy in Hypertensive Patients.A Real World Trial". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03371797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*